Mutant p53 in Cancer: New Functions and Therapeutic Opportunities

Slides:



Advertisements
Similar presentations
Origins of Metastatic Traits Sakari Vanharanta, Joan Massagué Cancer Cell Volume 24, Issue 4, Pages (October 2013) DOI: /j.ccr
Advertisements

Tumor-Derived Jagged1 Promotes Osteolytic Bone Metastasis of Breast Cancer by Engaging Notch Signaling in Bone Cells Nilay Sethi, Xudong Dai, Christopher.
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
2015 Alzheimer's disease facts and figures Alzheimer's & Dementia: The Journal of the Alzheimer's Association Volume 11, Issue 3, Pages (March.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Silvestri Gerard A. , MD, FCCP, Rivera M. Patricia , MD, FCCP  CHEST 
Reversing Neurodegeneration:A Promise Unfolds
“Atypical” Regulation of Hedgehog-Dependent Cancers
NF-κB: A Coordinator for Epigenetic Regulation by MLL
IRS-1: Auditing the effectiveness of mTOR inhibitors
Warren S. Pear, M. Celeste Simon  Cancer Cell 
Volume 21, Issue 3, Pages (March 2012)
The Path(way) Less Traveled: A Pathway-Oriented Approach to Providing Information about Precision Cancer Medicine on My Cancer Genome  Alexandria D. Taylor,
Metastasis gets site specific
Mutant p53 gain of function: The NF-Y connection
A Sweet New Role for EGFR in Cancer
George-Lucian Moldovan, Alan D. D'Andrea  Cancer Cell 
Cell signaling and cancer
Personalizing Therapy for Colorectal Cancer
Annapoorni Rangarajan, Sue J. Hong, Annie Gifford, Robert A. Weinberg 
Volume 26, Issue 1, Pages 1-2 (July 2014)
Kidney Cancer: Now Available in a New Flavor
Alyson A. Lokken, Nancy J. Zeleznik-Le  Cancer Cell 
Personalizing Therapy for Colorectal Cancer
A Radical Role for p38 MAPK in Tumor Initiation
Focus on multiple myeloma
Apoptosis-targeted therapies for cancer
Targeting the Undruggable Proteome: The Small Molecules of My Dreams
The p27Kip1 tumor suppressor gene: Still a suspect or proven guilty?
Volume 137, Issue 1, Pages (July 2009)
Volume 3, Issue 4, Pages (April 2003)
The great MYC escape in tumorigenesis
Axis Formation— β-Catenin Catches a Wnt
IRS-1: Auditing the effectiveness of mTOR inhibitors
FAL1ing inside an Amplicon
RalGDS comes of age Cancer Cell
Drugging Chromatin in Cancer: Recent Advances and Novel Approaches
Killing Lymphoma with Smac-Mimetics: As Easy as ABC?
LKB1 and Src: Antagonistic Regulators of Tumor Growth and Metastasis
Hard Times for Oncogenic BRAF-Expressing Melanoma Cells
Anoor Paripati, MBBS, Chris Kingsley, PhD, Glen J. Weiss, MD 
NO Signals from the Cancer Stem Cell Niche
Apoptosis-targeted therapies for cancer
John D. Gordan, Craig B. Thompson, M. Celeste Simon  Cancer Cell 
P53 and Prognosis Cell Volume 120, Issue 1, Pages 7-10 (January 2005)
Volume 14, Issue 4, Pages (October 2008)
Apoptosis Cell Volume 108, Issue 2, Pages (January 2002)
Volume 21, Issue 3, Pages (March 2012)
Autophagy SEPArates Germline and Somatic Cells
Metabolic Regulation by p53 Family Members
TFIID and MYB Share a Therapeutic Handshake in AML
To Infinium, and Beyond! Cancer Cell
FAL1ing inside an Amplicon
Discovery of a Secreted Tumor Suppressor Provides a Promising Therapeutic Strategy for Follicular Lymphoma  Marc R. Mansour, A. Thomas Look  Cancer Cell 
c-Raf in KRas Mutant Cancers: A Moving Target
Is Cyclin D1-CDK4 kinase a bona fide cancer target?
Volume 17, Issue 2, Pages (February 2010)
Connecting with an Old Partner in a New Way
Gankyrin: An intriguing name for a novel regulator of p53 and RB
Helge Großhans, Ingo Büssing  Cancer Cell 
Ibrutinib Treatment of CLL: The Cancer Fights Back
Mind the IQGAP Cancer Cell
Volume 12, Issue 6, Pages (December 2007)
Kidney Cancer: Now Available in a New Flavor
Anthony N. Imbalzano, Stephen N. Jones  Cancer Cell 
Skp2, the FoxO1 hunter Cancer Cell
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Volume 3, Issue 4, Pages (April 2003)
Presentation transcript:

Mutant p53 in Cancer: New Functions and Therapeutic Opportunities Patricia A.J. Muller, Karen H. Vousden  Cancer Cell  Volume 25, Issue 3, Pages 304-317 (March 2014) DOI: 10.1016/j.ccr.2014.01.021 Copyright © 2014 The Authors Terms and Conditions

Figure 1 Strategies that Are Currently Being Explored to Target Mutant p53 Depicted in red are schematics of the strategies that are currently being explored to target p53 mutant-expressing cancers. These strategies include promotion of mutant p53 degradation through the proteasome and autophagy pathways, restoration of wild-type p53 activity, interference with the interaction between mutant p53 and other proteins, and interference in signaling pathways downstream of mutant p53. Cancer Cell 2014 25, 304-317DOI: (10.1016/j.ccr.2014.01.021) Copyright © 2014 The Authors Terms and Conditions